Sep 03, 10 04:05AM
|
0 comments
The United States Orphan Drug Act (US ODA) was passed in 1983, as way to stimulate the development of new therapies for rare diseases. According to the US ODA, orphan drugs are promising therapies intended to treat diseases affecting fewer than 200,000 people in the U.S., Products that fall into this category are eligible to receive financial incentives, including federally-funded grants and
Contributor
More from this contributor
- 2nd Annual World Orphan Drug Con...
- How Biotech Companies are Shapin...
- Hiking the Appalachian Trail: Fi...
- The Undiagnosed Diseases Program...
Comments
To add a comment to the original post, click here.
You must be signed in to post a comment.
Sign in nowThere are no comments for this post.